Search results
Mar 15, 2024 · BENGALURU, India , March 15, 2024 /PRNewswire/ -- Pandorum Technologies, a leading biotechnology company, announced today the successful closure of a pre-Series B funding round, securing USD 11...
Feb 7, 2024 · Biotech startup Pandorum Technologies is raising $8 Mn (INR 64.8 Cr) in a fresh funding round from ace investor Ashish Kacholia, Everest Finance and Investment Company – the finance arm of ...
Amidst the chaos of Pandemic and vaccine development for COVID-19, Pandorum aspires to give post-trauma treatment for lung regeneration. We are developing a cell-free, safe treatment to repair the damage caused by inflammation and fibrosis. Our exosomal therapy will alleviate lung damage. About Pandorum. Our science.
Mar 19, 2024 · Pandorum Technologies has closed on $11 million following a pre-Series B funding round in support of clinical advancement for its flagship product. Give me the rundown on Pandorum.
Pandorum Technology is a tissue engineering and regenerative medicine company that uses the foundational and translational principles of biology and engineering to design world class therapeutic products, that aim to alleviate the health conditions of patient’s suffering from on corneal dystrophies, lung related disorders and liver diseases.
Sep 7, 2020 · Pandorum has raised more than INR 41 Cr by issuing Pre-Series B Cumulative Compulsorily Convertible Preference Shares (CCCPS) to several entities. The investors include BTB Ventures and Karnataka...
People also ask
What happened to Pandorum technologies?
Who owns Pandorum technologies?
What is Pandorum Technology?
How much money has Pandorum Technologies raised?
Pandorum is currently engaged in clinical manufacturing process and IND enabling studies of Kuragenx, with the aim towards the first patient dosing in 2025, after obtaining due regulatory approvals. "Giving back vision with something made in the lab, without depending on donor corneas, is truly transformative.
